FIBROGEN INC (FGEN) Share-based Payment Arrangement, Expense USD 2014 - 2021

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fibrogen Inc annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2021.
  • Fibrogen Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2021 was $17.1 M, a 15.8% decline year-over-year.
  • Fibrogen Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2021 was $71.2 M, a 2.14% decline year-over-year.
  • Fibrogen Inc annual Share-based Payment Arrangement, Expense for 2023 was $50.8 M, a 22.6% decline from 2022.
  • Fibrogen Inc annual Share-based Payment Arrangement, Expense for 2022 was $65.6 M, a 7.81% decline from 2021.
  • Fibrogen Inc annual Share-based Payment Arrangement, Expense for 2021 was $71.2 M, a 2.14% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2021 $71.2 M $17.1 M -$3.2 M -15.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $74.4 M $15.7 M -$2.19 M -12.2% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $76.5 M $19 M +$1.36 M +7.69% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $75.2 M $19.4 M +$2.47 M +14.6% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $72.7 M $20.3 M +$2.87 M +16.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $69.9 M $17.9 M +$3.1 M +20.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $66.8 M $17.6 M +$2 K +0.01% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $66.8 M $16.9 M +$486 K +2.96% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $66.3 M $17.4 M +$3.69 M +26.9% Oct 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
Q3 2019 $62.6 M $14.8 M +$470 K +3.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $62.1 M $17.6 M +$4.41 M +33.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $57.7 M $16.4 M +$5.55 M +51% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $52.1 M $13.7 M +$3.78 M +38.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $48.4 M $14.3 M +$4.7 M +48.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $43.7 M $13.2 M +$3.66 M +38.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $40 M $10.9 M +$2.47 M +29.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $37.5 M $9.93 M +$2.06 M +26.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $35.5 M $9.63 M +$1.12 M +13.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $34.4 M $9.57 M +$1.17 M +13.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $33.2 M $8.41 M +$1.07 M +14.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $32.1 M $7.88 M +$427 K +5.73% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $31.7 M $8.51 M +$1.67 M +24.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $30 M $8.4 M +$1.46 M +21.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $28.6 M $7.34 M +$894 K +13.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $27.7 M $7.45 M -$1.52 M -16.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $29.2 M $6.84 M -$1.43 M -17.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $30.6 M $6.94 M +$6.27 M +936% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $24.3 M $6.45 M +$5.65 M +711% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $18.7 M $8.96 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $8.27 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $670 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $795 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.